Identification of CASZ1 NES reveals potential mechanisms for loss of CASZ1 tumor suppressor activity in neuroblastoma

被引:0
|
作者
Z Liu
N Lam
E Wang
R A Virden
B Pawel
E F Attiyeh
J M Maris
C J Thiele
机构
[1] Pediatric Oncology Branch,
[2] National Cancer Institute,undefined
[3] Children's Hospital of Philadelphia,undefined
[4] University of Pennsylvania,undefined
来源
Oncogene | 2017年 / 36卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
As a transcription factor, localization to the nucleus and the recruitment of cofactors to regulate gene transcription is essential. Nuclear localization and nucleosome remodeling and histone deacetylase (NuRD) complex binding are required for the zinc-finger transcription factor CASZ1 to function as a neuroblastoma (NB) tumor suppressor. However, the critical amino acids (AAs) that are required for CASZ1 interaction with NuRD complex and the regulation of CASZ1 subcellular localization have not been characterized. Through alanine scanning, immunofluorescence cell staining and co-immunoprecipitation, we define a critical region at the CASZ1 N terminus (AAs 23–40) that mediates the CASZ1b nuclear localization and NuRD interaction. Furthermore, we identified a nuclear export signal (NES) at the N terminus (AAs 176–192) that contributes to CASZ1 nuclear-cytoplasmic shuttling in a chromosomal maintenance 1-dependent manner. An analysis of CASZ1 protein expression in a primary NB tissue microarray shows that high nuclear CASZ1 staining is detected in tumor samples from NB patients with good prognosis. In contrast, cytoplasmic-restricted CASZ1 staining or low nuclear CASZ1 staining is found in tumor samples from patients with poor prognosis. These findings provide insight into mechanisms by which CASZ1 regulates transcription, and suggests that regulation of CASZ1 subcellular localization may impact its function in normal development and pathologic conditions such as NB tumorigenesis.
引用
收藏
页码:97 / 109
页数:12
相关论文
共 50 条
  • [31] The Prognostic Significance of Protein Expression of CASZ1 in Clear Cell Renal Cell Carcinoma
    Kim, Bohyun
    Jung, Minsun
    Moon, Kyung Chul
    DISEASE MARKERS, 2019, 2019
  • [32] Differential Regulation of CASZ1 Protein Expression During Cardiac and Skeletal Muscle Development
    Amin, Nirav M.
    Gibbs, Devin
    Conlon, Frank L.
    DEVELOPMENTAL DYNAMICS, 2014, 243 (07) : 948 - 956
  • [33] CASZ1 promotes migration, invasion, and metastasis of lung cancer cells by controlling expression of ITGAV
    Baghmisheh, Sina Taheri
    Wu, Yi-Ying
    Wu, Jia-En
    Hsu, Keng-Fu
    Chen, Yuh-Ling
    Hong, Tse-Ming
    AMERICAN JOURNAL OF CANCER RESEARCH, 2023, 13 (01): : 176 - 189
  • [34] Essential Role of the Zinc Finger Transcription Factor Casz1 for Mammalian Cardiac Morphogenesis and Development
    Liu, Zhihui
    Li, Wenling
    Ma, Xuefei
    Ding, Nancy
    Spallotta, Francesco
    Southon, Eileen
    Tessarollo, Lino
    Gaetano, Carlo
    Mukouyama, Yoh-suke
    Thiele, Carol J.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (43) : 29801 - 29816
  • [35] Transcription factor CASZ1 increases an oncogenic transcriptional process in tumorigenesis and progression of glioma cells
    Mao, Chaofu
    Huang, Chengying
    Hu, Zhicheng
    Qu, Shanqiang
    MEDCOMM, 2022, 3 (04):
  • [36] Congenital heart disease protein 5 associates with CASZ1 to maintain myocardial tissue integrity
    Sojka, Stephen
    Amin, Nirav M.
    Gibbs, Devin
    Christine, Kathleen S.
    Charpentier, Marta S.
    Conlon, Frank L.
    DEVELOPMENT, 2014, 141 (15): : 3040 - 3049
  • [37] Transcriptional regulation of blood vessel formation The role of the CASZ1/Egfl7/RhoA pathway
    Charpentier, Marta S.
    Dorr, Kerry M.
    Conlon, Frank L.
    CELL CYCLE, 2013, 12 (14) : 2165 - 2166
  • [38] CASZ1 suppresses neuroblastoma cell growth by restoring Rb activity in G1 and regulating kinases involved in G2/M progression
    Liu, Zhihui
    Rader, JulieAnn
    Thiele, Carol
    CANCER RESEARCH, 2011, 71
  • [39] Casz1 is required for cardiomyocyte G1-to-S phase progression during mammalian cardiac development
    Dorr, Kerry M.
    Amin, Nirav M.
    Kuchenbrod, Lauren M.
    Labiner, Hanna
    Charpentier, Marta S.
    Pevny, Larysa H.
    Wessels, Andy
    Conlon, Frank L.
    DEVELOPMENT, 2015, 142 (11): : 2037 - 2047
  • [40] Mutant RAS represses CASZ1, a novel regulator of MYOD and MYOG, to inhibit embryonal rhabdomyosarcoma differentiation
    Liu, Zhihui
    Zhang, Xiyuan
    Lei, Haiyan
    Lam, Norris
    Yockey, Oliver
    Xu, Max
    Mendoza, Arnulfo
    Wei, Jun S.
    Khan, Javed
    Yohe, Marielle E.
    Shern, Jack F.
    Thiele, Carol J.
    CANCER RESEARCH, 2020, 80 (14) : 101 - 101